In-vitro assays also denoted that lncRNA H19 overexpression could facilitate PCa cell proliferation, invasion, and migration and suppress apoptosis, whereas lncRNA H19 down-expression could produce the opposite phenomenon, showing that lncRNA H19 could exert a promotive function in prostate cancer. This evidence concerns the gene H19 and prostate cancer.